| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034606759 |
| P356 | DOI | 10.1186/S12872-016-0246-Y |
| P932 | PMC publication ID | 4837614 |
| P698 | PubMed publication ID | 27095611 |
| P50 | author | Anna Dominiczak | Q4766963 |
| Christian Delles | Q43096626 | ||
| Sabrina H Rossi | Q57067619 | ||
| Harald Mischak | Q37828676 | ||
| P2093 | author name string | Colin Berry | |
| Keith G Oldroyd | |||
| Erin Olson | |||
| Thomas Koeck | |||
| Jane A Dymott | |||
| David M Carty | |||
| Ulf Neisius | |||
| P2860 | cites work | Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal. | Q38517255 |
| The unstable atheroma | Q41627468 | ||
| Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals | Q42920025 | ||
| Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease | Q46243933 | ||
| Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients | Q56970703 | ||
| Urinary Proteomic Biomarkers in Coronary Artery Disease | Q56970751 | ||
| 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary | Q61667402 | ||
| The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life | Q67674363 | ||
| Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries | Q68201942 | ||
| A more meaningful scoring system for determining the severity of coronary heart disease | Q71657544 | ||
| Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease | Q71730394 | ||
| Hibernating myocardium: an incomplete adaptation to ischemia | Q73914782 | ||
| Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease | Q74296886 | ||
| Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques | Q77756578 | ||
| Differential associations of renal function with coronary and peripheral atherosclerosis | Q81540314 | ||
| Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association | Q30434464 | ||
| Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis | Q30439686 | ||
| Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches | Q31153391 | ||
| Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology | Q33996248 | ||
| Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease | Q34129628 | ||
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on pra | Q34312736 | ||
| The relation between neutrophil-to-lymphocyte ratio and coronary chronic total occlusions | Q34333080 | ||
| The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease | Q34404142 | ||
| Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species | Q34808126 | ||
| Inflammation and restenosis in the stent era. | Q34993928 | ||
| Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology | Q35789818 | ||
| Mechanisms of post-intervention arterial remodelling | Q36404987 | ||
| Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. | Q36654798 | ||
| Ageing of the conduit arteries | Q36698238 | ||
| Urine in clinical proteomics | Q37230698 | ||
| Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients | Q38012933 | ||
| Proteomics in hypertension and other cardiovascular diseases | Q38020003 | ||
| Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience | Q38049916 | ||
| Widening clinical applications of the SYNTAX Score. | Q38123467 | ||
| P304 | page(s) | 70 | |
| P577 | publication date | 2016-04-19 | |
| P1433 | published in | BMC Cardiovascular Disorders | Q15753126 |
| P1476 | title | Urine proteomics in the diagnosis of stable angina | |
| P478 | volume | 16 |
| Q36214366 | Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease |
| Q33728667 | Evaluation of the systemic micro- and macrovasculature in stable angina: A case-control study |
| Q57175639 | Integrating Genes Affecting Coronary Artery Disease in Functional Networks by Multi-OMICs Approach |
| Q91755162 | Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future |
| Q38780174 | Proteomics in cardiovascular disease: recent progress and clinical implication and implementation. |
| Q58227790 | Utilizing proteomics to understand and define hypertension: where are we and where do we go? |
Search more.